DNA-based interleukin-12

Showing: 1 - 1 of 1 Articles

"Ovarian Cancer Treatment Clinical Trial"

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation …

vinay February 27, 2024February 27, 2024